Announce Date | 12/31/1969 |
EPS Normalized Actual | $ In Line |
EPS GAAP Actual | $ In Line |
Revenue Actual | $0.032007B |
Revenue Surprise | Beat by $32.007M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.043333 |
EPS GAAP Estimate | $-0.043333 |
Revenue Estimate | $0.0322905B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 0 | INF | 0 | 0 | 0 |
Dec 2027 | 0 | INF | 0 | 0 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.01 | -0.01 | 0.032007B | 32.3% | 5.14M |
FQ3 2024 (Sep 2024) | -0.19 | -0.19 | 0.02736B | 26.2% | 0.94M |
FQ4 2024 (Dec 2024) | -0.0989 | -0.0989 | 0.0291B | 25.01% | 29.1M |
FQ2 2024 (Jun 2024) | 0.0221 | 0.1096 | 0.02554B | 22.38% | 1.7M |
FQ1 2024 (Mar 2024) | -0.0761 | 0.010567 | 0.021668B | 14.25% | -1.14M |
FQ4 2023 (Dec 2023) | -0.11 | -0.0175 | 0.021821B | 67.18% | 2.5M |
FQ3 2023 (Sep 2023) | 0.0399 | 0.1499 | 0.020191B | 100% | 1.29M |
FQ2 2023 (Jun 2023) | -0.0004 | 0.1171 | 0.019825B | 100% | 5.55M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.043333
Consensus Revenue Estimates
0.0322905B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | -0.033333 | -- | -0.0355105 | -0.03095666 | 1 |
FQ2 2026 (Jun 2026) | -0.036667 | -- | -0.03906229 | -0.03405297 | 1 |
FQ1 2026 (Mar 2026) | -0.04 | 75 | -0.04261302 | -0.03714836 | 1 |
FQ3 2025 (Sep 2025) | -0.043333 | -338.46 | -0.04616375 | -0.04024375 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2026 (Sep 2026) | 0.04B | -- | 0.04B | 0.04B | 2 |
FQ2 2026 (Jun 2026) | 0.04B | -- | 0.04B | 0.04B | 2 |
FQ1 2026 (Mar 2026) | 0.04B | 10.07 | 0.03B | 0.04B | 3 |
FQ3 2025 (Sep 2025) | 0.03B | 15.27 | 0.03B | 0.03B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0 | -0.01 | -0.01 | 100% |
FQ3 2024 (Sep 2024) | 0 | -0.19 | -0.19 | 100% |
FQ4 2024 (Dec 2024) | -0.0989 | -0.0989 | 100% | |
FQ2 2024 (Jun 2024) | -0.0875 | 0.0221 | 0.1096 | 495.93% |
FQ1 2024 (Mar 2024) | -0.086667 | -0.0761 | 0.010567 | -13.89% |
FQ4 2023 (Dec 2023) | -0.0925 | -0.11 | -0.0175 | 15.91% |
FQ3 2023 (Sep 2023) | -0.11 | 0.0399 | 0.1499 | 375.69% |
FQ2 2023 (Jun 2023) | -0.1175 | -0.0004 | 0.1171 | -29275% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0.03B | $0.03B | $5.14M | 16.07% |
FQ3 2024 (Sep 2024) | $0.03B | $0.03B | $0.94M | 3.44% |
FQ4 2024 (Dec 2024) | $0B | $0.03B | $29.1M | 100% |
FQ2 2024 (Jun 2024) | $0.02B | $0.03B | $1.7M | 6.66% |
FQ1 2024 (Mar 2024) | $0.02B | $0.02B | $-1.14M | -5.26% |
FQ4 2023 (Dec 2023) | $0.02B | $0.02B | $2.5M | 11.46% |
FQ3 2023 (Sep 2023) | $0.02B | $0.02B | $1.29M | 6.39% |
FQ2 2023 (Jun 2023) | $0.01B | $0.02B | $5.55M | 27.99% |